2-Chloro-6-methoxy-3-(trifluoromethyl)pyridine, 95.0%, 1g

2-METHYL-1,4-NAPHTHOHYDROQUINONE, 95.0%, 10mg

4-Pyrrolidinopyridine, 95.0%, 500g

2-Hydroxy-3-methylbutanoic acid, 95.0%, 25g

1-Bromo-3-butan-2-yloxybenzene, 5g

2,5-Dimethylterephthalonitrile, 97.0%, 1g

Potassium hexacyanoferrate(III), ROTI®METIC 99.99% (4N), 5 g, HDPE

4-Chloro-3-methoxy-5-nitrobenzamide, 97%, 5g

2-Propenoic acid, 3-(1H-indol-3-yl)-, (2E)-, 95%, 1g

(E)-5-(4-(3,5-dimethyl-4-nitrostyryl)benzamido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid hydrate, 98%, 5mg

BioBlue.Lab BB.1152-PLPHi Biocular with 10x/20x/S40x/S100x plan phase IOS objectives and Rackless cross table

(2R,3S)-2-Amino-3-hydroxy-4-methylpentanoic acid, 95.0%, 100mg

ETHYL 2-(METHYLSULFONYL)PROPANOATE, 95.0%, 10g